The purpose of the present work was to further characterize the tumor-specific localization of the NIRF and PET signals from the MMP-14 targeted peptide probes indicated above relative to the performance of 5-ALA as a clinically validated intraoperative imaging agent for GBM. The gene discussed is MMP14; the disease is neoplasm.